Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Testosterone significantly affects urination differences between male and female mice.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Testosterone therapy increases bone density in older men with low testosterone levels.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Corn silk extract helps reduce prostate enlargement symptoms.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Dosing time affects finasteride's effectiveness and safety in rats.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.